The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Antibiotic resistance is the quintessential One Health issue
Open accessAbstract
In May this year, the long-awaited final report from the Review on Antimicrobial Resistance was published. 1 The report estimates that the 700 000 annual deaths currently attributable to infections by drug-resistant pathogens will increase, if unchecked, to 10 million by 2050, running up a bill of US$100 trillion in terms of lost global production between now and then. The reported numbers are somewhat apocalyptic, as they are based on crude projections of current trends and presume the failure of anti-malarial drugs and antiretroviral therapy as well as antibiotics. Nor do they account for the possible entry of new drugs onto the market. There is huge uncertainty associated with the human burden of antimicrobial resistance (AMR) in general and antibiotic resistance in particular (for the purpose of this article the widely used term antimicrobial resistance [AMR] is retained, though the emphasis here is on antibiotic resistance). The precision of the estimates does not really matter much: the point is that the problem is already immense and is growing rapidly. We have been squandering our antibiotic resources for far too long and immediate action is needed on a very large scale if we are to reverse current trends. It is difficult to imagine an issue that epitomises the principles of One Health more than AMR does. The One Health approach, defined as ‘...the collaborative effort of multiple disciplines – working locally, nationally, and globally – to attain optimal health for people, animals and our environment…’, 2 recognises that the health of people is connected to the health of animals and the environment. AMR has clear links to each of these three domains. The contribution of animal production, both terrestrial livestock and aquaculture, to the global AMR crises is questioned by some on the grounds that we don't see so many animal-associated infections in humans. 3 While this may be true, because of the way that many antibiotics are used in animal production, in sub-therapeutic doses and with long exposure periods, these production systems create ideal conditions for bacteria to fix genes that confer resistance. These genes can subsequently be transmitted to human-adapted pathogens or to human gut microbiota via people, contaminated food or the environment. They also provide ideal conditions for the amplification of genes that may have arisen in people or the environment. The fact that the antibiotics used in human and animal health largely comprise the same or very similar molecules would be expected to drive the transmission of resistance between animals and people, either directly or via the environment. Of the three domains, human health takes the spotlight, with multidrug-resistance genes now highly prevalent in many important and common pathogens like Escherichia coli , Klebsiella pneumoniae and Staphylococcus aureus. Quite apart from the many infectious diseases for which we rely on antibiotics to combat, these drugs underpin modern medicine by allowing us to carry out common surgical procedures and treatments that depress the immune system, such as chemotherapy to treat cancer. The global burden of AMR on the population has been estimated, 1 , 4 and more specific studies have also been carried out; for example, the estimated 214 000 neonatal deaths attributable to resistant sepsis infections globally in 2013; 111 523 occurring in the five countries with the highest numbers of neonatal deaths in the world: India, Pakistan, Nigeria, Democratic Republic of Congo and China. 5 Such estimates of the burden of AMR have not been attempted for livestock or aquaculture, perhaps due to a perceived lower importance. Resistance to antibiotics among mastitis pathogens, for example, is well documented though it is not considered to be an emerging or a progressing problem. 6 Recent estimates of the amount of antibiotics consumed in livestock production conservatively place this at 63 151 tonnes in 2010. 7 The situation is less clear in aquaculture. 8 Although actual figures are currently unavailable, the published estimates of the proportion of antibiotics consumed in animal agriculture—84% (for 36 antibiotics) in China 9 and 70% in USA 10 —suggest global agricultural consumption probably exceeds that of humans. A large part of this use is justified and valid on veterinary grounds, 6 but there is much misuse in the agricultural sector. With such large consumption levels it seems likely that agricultural use contributes significantly to AMR. A recent review suggested that misuse of antimicrobials in animal production is a clear and substantial driver of AMR, 11 and there is a growing body of evidence linking antibiotic consumption in livestock to AMR in the clinic. 12 Many infections in people are endogenous; derived from the human gut flora. An important gap in knowledge relates to the possible extent and mechanisms of transmission of antibiotic resistance genes between the normal gut flora of animals and that o
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Early-warning signals for critical transitions
Scheffer, M., Bascompte, J., Brock, W. A., Brovkin, V., Carpenter, S. R., Dakos, V., Held, H., van Nes, E. H., Rietkerk, M., & Sugihara, G. (2009) · Nature · doi:10.1038/nature08227 · Cited by 4,854
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Self-citationZhang, Q.-Q., Ying, G.-G., Pan, C.-G., Liu, Y.-S., & Zhao, J.-L. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b00729 · Cited by 3,852
Whitmee, S., Haines, A., Beyrer, C., Boltz, F., Capon, A. G., de Souza Dias, B. F., Ezeh, A., Frumkin, H., Gong, P., Head, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60901-1 · Cited by 2,998
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
Effluent from drug manufactures contains extremely high levels of pharmaceuticals
Larsson, D. G. J., de Pedro, C., & Paxeus, N. (2007) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2007.07.008 · Cited by 1,612
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationThe World Health Organization Global Action Plan for antimicrobial resistance
Mendelson, M., & Matsoso, M. P. (2015) · South African Medical Journal · doi:10.7196/samj.9644 · Cited by 1,155
Ji, X., Shen, Q., Liu, F., Ma, J., Xu, G., Wang, Y., & Wu, M. (2012) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2012.07.040 · Cited by 875
Antibiotics in agriculture and the risk to human health: how worried should we be?
Chang, Q., Wang, W., Regev‐Yochay, G., Lipsitch, M., & Hanage, W. P. (2015) · Evolutionary Applications · doi:10.1111/eva.12185 · Cited by 562
Antibiotic resistance of E. coli in sewage and sludge
Reinthaler, F. F., Posch, J., Feierl, G., Wüst, G., Haas, D., Ruckenbauer, G., Mascher, F., & Marth, E. (2003) · Water Research · doi:10.1016/s0043-1354(02)00569-9 · Cited by 556
The role of natural environments in the evolution of resistance traits in pathogenic bacteria
Martinez, J. L. (2009) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.0320 · Cited by 513
McGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350
STOCKWELL, V. O., & DUFFY, B. (2012) · Revue Scientifique et Technique de l'OIE · doi:10.20506/rst.31.1.2104 · Cited by 332
NDM-1 — A Cause for Worldwide Concern
Moellering, R. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1011715 · Cited by 312
Antibiotics and antibiotic-resistant bacteria in waters associated with a hospital in Ujjain, India
Diwan, V., Tamhankar, A. J., Khandal, R. K., Sen, S., Aggarwal, M., Marothi, Y., Iyer, R. V., Sundblad-Tonderski, K., & Stålsby- Lundborg, C. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-414 · Cited by 275
Antimicrobial Resistance of Mastitis Pathogens
Oliver, S. P., & Murinda, S. E. (2012) · Veterinary Clinics of North America: Food Animal Practice · doi:10.1016/j.cvfa.2012.03.005 · Cited by 265
Executive summary of the AVMA One Health Initiative Task Force report
King, L. J., Anderson, L. R., Blackmore, C. G., Blackwell, M. J., Lautner, E. A., Marcus, L. C., Meyer, T. E., Monath, T. P., Nave, J. E., Ohle, J., et al. (2008) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.233.2.259 · Cited by 175
Policy: An intergovernmental panel on antimicrobial resistance
Woolhouse, M. E. J., & Farrar, J. (2014) · Nature · doi:10.1038/509555a · Cited by 162
Self-citationAntimicrobial use in aquaculture: Some complementing facts
Henriksson, P. J. G., Troell, M. F., & Rico, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508952112 · Cited by 31
Cited by
Antimicrobial Resistance: a One Health Perspective
McEwen, S. A., & Collignon, P. J. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0009-2017 · Cited by 1,199
Antimicrobial Resistance (AMR)
Tang, K. W. K., Millar, B. C., & Moore, J. E. (2023) · British Journal of Biomedical Science · doi:10.3389/bjbs.2023.11387 · Cited by 1,009
Urbanization and Disease Emergence: Dynamics at the Wildlife–Livestock–Human Interface
Hassell, J. M., Begon, M., Ward, M. J., & Fèvre, E. M. (2017) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2016.09.012 · Cited by 808
Self-citationCollignon, P., Beggs, J. J., Walsh, T. R., Gandra, S., & Laxminarayan, R. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30186-4 · Cited by 750
Self-citationEnvironmental antimicrobial resistance and its drivers: a potential threat to public health
Samreen, Ahmad, I., Malak, H. A., & Abulreesh, H. H. (2021) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2021.08.001 · Cited by 727
Metadata
- Authors
- Robinson, T. P., Bu, D. P., Carrique-Mas, J., Fèvre, E. M., Gilbert, M., Grace, D., Hay, S. I., Jiwakanon, J., Kakkar, M., Kariuki, S., Laxminarayan, R., Lubroth, J., Magnusson, U., Thi Ngoc, P., Van Boeckel, T. P., & Woolhouse, M. E. J.
- Venue
- Transactions of The Royal Society of Tropical Medicine and Hygiene
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-07
- Volume
- 110
- Issue
- 7
- Pages
- 377-380
- ISSN
- 0035-9203 (ISSN-L)
- 1878-3503
- OpenAlex
- W2498603190
- Cited by
- 828
- References
- 21
- FWCI
- 31.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.